INHIBRX, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.17 USD | -4.72% |
|
-49.66% | -54.82% |
| Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
| May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
Business Summary
Number of employees: 169
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Biological Therapeutic Candidates
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 2 | 100.0 % | -17.88% |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 52,401,941 | 38,872,072 ( 74.18 %) | 0 | 74.18 % |
Company contact information
Inhibrx, Inc.
11025 North Torrey Pines Road Suite 200
92037, La Jolla
+858 795 4220
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -54.82% | 1.79B | |
| +16.73% | 123B | |
| +13.04% | 107B | |
| -5.80% | 24.01B | |
| +2.10% | 22.59B | |
| -10.09% | 18.16B | |
| -40.52% | 16.84B | |
| -14.00% | 16.23B | |
| +1.18% | 13.43B | |
| +24.18% | 11.32B |
- Stock Market
- Equities
- INBX Stock
- Company Inhibrx, Inc.
